Walgreens Boots Alliance (Nasdaq:WBA) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

WBA 주식 개요

는 미국, 영국, 독일 및 전 세계에서 의료, 약국 및 소매 회사로 운영되고 있습니다.

WBA 기본 분석
눈송이 점수
가치 평가	5/6
미래 성장	3/6
과거 실적	0/6
재무 상태	2/6
배당금	2/6

보상

공정 가치 추정치보다 낮은 67.4% 에서 거래

수익은 매년 67.65% 증가할 것으로 예상됩니다.

동종업계 및 업계 대비 좋은 가치로 거래

위험 분석

6.21% 의 배당금은 수익이나 현금 흐름으로 잘 감당되지 않습니다.

부채는 영업현금흐름으로 충분히 감당되지 않습니다.

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Critical Overhaul And Digital Investments Set To Revitalize Profitability And Market Share

US$12.43

27.9% undervalued

1.44%

Revenue growth p.a.

1 day ago

Walgreens Boots Alliance, Inc. 경쟁사

Guardian Pharmacy Services

NYSE:GRDN

US$1.1b

Maplebear

NasdaqGS:CART

US$10.3b

Sprouts Farmers Market

NasdaqGS:SFM

US$10.8b

Albertsons Companies

NYSE:ACI

US$10.7b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Walgreens Boots Alliance
과거 주가
현재 주가	US$8.96
52주 최고치	US$27.05
52주 최저치	US$8.22
베타	0.68
11개월 변경	-3.14%
3개월 변경 사항	-22.56%
1년 변경 사항	-60.04%
33년 변화	-80.81%
5년 변화	-83.02%
IPO 이후 변화	2,697.26%

최근 뉴스 및 업데이트

Recent updates

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Sep 29

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Sep 09

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Sep 06

Is Walgreens Ready To Rebound?

Aug 23

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48

Aug 01

Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48

Jul 16

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Jul 04

주주 수익률

	WBA	US Consumer Retailing	US 마켓
7D	4.7%	-0.6%	0.8%
1Y	-60.0%	42.2%	33.4%

수익률 대 산업: WBA 지난 1년 동안 29.8 %를 반환한 US Consumer Retailing 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: WBA 지난 1년 동안 23.3 %를 반환한 US 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is WBA's price volatile compared to industry and market?
WBA volatility
WBA Average Weekly Movement	6.2%
Consumer Retailing Industry Average Movement	6.1%
Market Average Movement	6.4%
10% most volatile stocks in US Market	14.8%
10% least volatile stocks in US Market	3.1%

안정적인 주가: WBA 의 주가는 지난 3개월 동안 변동성이 심했습니다.

시간에 따른 변동성: WBA 의 주간 변동성( 6% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1909	268,500	Tim Wentworth	www.walgreensbootsalliance.com

는 미국, 영국, 독일 및 전 세계에서 의료, 약국 및 소매 회사로 운영되고 있습니다. 이 회사는 세 가지 부문으로 운영됩니다: 미국 소매 약국, 국제 및 미국 헬스케어입니다. 미국 소매 약국 부문은 소매 약국, 건강 및 웰빙 서비스, 전문 및 가정 배달 약국 서비스를 운영하며 건강 및 웰빙, 미용, 개인 관리 및 소모품, 일반 상품을 제공합니다.

Walgreens Boots Alliance, Inc. 기본 사항 요약

Walgreens Boots Alliance 의 수익과 매출은 시가총액과 어떻게 비교하나요?
WBA 기본 통계
시가총액	US$7.82b
수익(TTM)	-US$5.81b
수익(TTM)	US$145.53b

0.1x

P/S 비율

-1.3x

P/E 비율

WBA 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
WBA 손익 계산서(TTM)
수익	US$145.53b
수익 비용	US$118.79b
총 이익	US$26.75b
기타 비용	US$32.56b
수익	-US$5.81b

최근 보고된 수익

May 31, 2024

다음 수익 날짜

Oct 15, 2024

주당 순이익(EPS)	-6.73
총 마진	18.38%
순이익 마진	-3.99%
부채/자본 비율	57.8%

WBA 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

11.2%

현재 배당 수익률

-22%

지급 비율

WBA 주식 개요

보상

위험 분석

Critical Overhaul And Digital Investments Set To Revitalize Profitability And Market Share

Walgreens Boots Alliance, Inc. 경쟁사

NYSE:GRDN

US$1.1b

NasdaqGS:CART

US$10.3b

NasdaqGS:SFM

US$10.8b

NYSE:ACI

US$10.7b

가격 내역 및 성능

최근 뉴스 및 업데이트

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Recent updates

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Is Walgreens Ready To Rebound?

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Walgreens: A Painful Turnaround Lesson

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Walgreens: Here's What Comes Next

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024